The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Microbial systems are a black box. We created Microbial INtelligence Explorer to “MINE” their secrets• Microbiotica Raises $48 Million Series C to Advance Pipeline into Phase 2 Clinical Development• Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination•

Category: Research

Symberix Announces Non-Dilutive Funding Support for Lead Programs
Finance

Symberix Announces Non-Dilutive Funding Support for Lead Programs

OCT 22, 2018
LNC Therapeutics Acquires Exclusive License for the Christensenella Patent from Cornell University
Pharma & Human Health

LNC Therapeutics Acquires Exclusive License for the Christensenella Patent from Cornell University

OCT 17, 2018
Researchers Link Gut Bacteria to Heart Transplant Success or Failure
Pharma & Human Health

Researchers Link Gut Bacteria to Heart Transplant Success or Failure

OCT 11, 2018
Gram-negative Bacteria Increase Mortality, Vasopressor use and ICU Admission in ILD Patients
Pharma & Human Health

Gram-negative Bacteria Increase Mortality, Vasopressor use and ICU Admission in ILD Patients

OCT 5, 2018
Gut Bacteria’s Shocking Secret: They Produce Electricity
Pharma & Human Health

Gut Bacteria’s Shocking Secret: They Produce Electricity

SEP 17, 2018
BioCollective CEO Wins Science & Innovation Award for Collaborative Microbiome Scientific Discovery Platform
Pharma & Human Health

BioCollective CEO Wins Science & Innovation Award for Collaborative Microbiome Scientific Discovery Platform

AUG 21, 2018
Synlogic Publishes Preclinical Data Supporting Development of SYNB1618, a Synthetic Biotic™ Medicine as a Potential Treatment for Phenylketonuria
Biotics and Supplements

Synlogic Publishes Preclinical Data Supporting Development of SYNB1618, a Synthetic Biotic™ Medicine as a Potential Treatment for Phenylketonuria

AUG 16, 2018
THE ROLE OF BIOFILMS: An Interview with Scioto Biosciences
Animal Health

THE ROLE OF BIOFILMS: An Interview with Scioto Biosciences

AUG 3, 2018
Changes in bacterial mix linked to antibiotics increase risk for type 1 diabetes
Pharma & Human Health

Changes in bacterial mix linked to antibiotics increase risk for type 1 diabetes

JUL 26, 2018
Quadrant Biosciences: Researchers Discover Key Link to Understanding Sleep Disorders
Pharma & Human Health

Quadrant Biosciences: Researchers Discover Key Link to Understanding Sleep Disorders

JUL 20, 2018
Locus Biosciences acquires EpiBiome’s high-throughput discovery platform to enhance its global leadership in CRISPR-engineered phage therapeutics
Finance

Locus Biosciences acquires EpiBiome’s high-throughput discovery platform to enhance its global leadership in CRISPR-engineered phage therapeutics

JUL 17, 2018